340B Drug Pricing Program
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Melinda Hatton
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient…
AHA v. The Department of Health and Human Services Reply in Support of Defendants' Motion for a Stay
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs,
v.
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants.
No. 1:18-cv-02112-JDB
REPLY IN SUPPORT OF DEFENDANTS’ MOTION FOR A STAY
The AHA and other hospital groups today opposed the Department of Health and Human Services motion to stay in the groups’ lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.
Testimony for House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, October 11, 2017.
Testimony of Dr. Charles Daniels House Energy and Commerce Committee 340B Oversight Hearing, July 11, 2018.
The AHA is deeply disappointed in certain proposals that CMS has chosen to set forth in this proposed rule for the CY 2019 outpatient prospective payment system (OPPS), which run afoul of the law and rely on the most cursory of analyses and policy rationales. Taken together, they would have a…
Leaders from the AHA and individual 340B hospitals today came together to announce new principles for ensuring good stewardship of the 340B program. The new AHA-led initiative seeks to strengthen the 340B program by increasing transparency while helping 340B hospitals better publicly communicate…